We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+4.29%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$20.7B
AUM Growth
-$166M
Cap. Flow
-$582M
Cap. Flow %
-2.82%
Top 10 Hldgs %
30.44%
Holding
2,896
New
52
Increased
415
Reduced
1,909
Closed
89

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$65.1M
2
AAPL icon
Apple
AAPL
+$58M
3
MSFT icon
Microsoft
MSFT
+$49.2M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$25.9M
5
AL
Air Lease Corp
AL
+$21.6M

Sector Composition

Rank Sector Weight
1 Technology 30.28%
2 Financials 13.29%
3 Healthcare 10.43%
4 Consumer Discretionary 10.39%
5 Industrials 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCB icon
1526
Coastal Financial
CCB
$754M
$837K ﹤0.01%
7,307
-418
-5% -$45.6K
GTY
1527
Getty Realty Corp
GTY
$2.04B
$837K ﹤0.01%
30,569
-1,655
-5% -$45.7K
NBHC icon
1528
National Bank Holdings
NBHC
$1.94B
$836K ﹤0.01%
21,987
DXPE icon
1529
DXP Enterprises
DXPE
$3.04B
$833K ﹤0.01%
7,585
ABR icon
1530
Arbor Realty Trust
ABR
$981M
$831K ﹤0.01%
107,131
-2,245
-2% -$22K
TCBK icon
1531
TriCo Bancshares
TCBK
$1.86B
$825K ﹤0.01%
17,419
SBH icon
1532
Sally Beauty Holdings
SBH
$1.55B
$823K ﹤0.01%
+57,681
New +$869K
NNI icon
1533
Nelnet
NNI
$4.52B
$822K ﹤0.01%
6,185
-1,286
-17% -$168K
COLL icon
1534
Collegium Pharmaceutical
COLL
$913M
$822K ﹤0.01%
17,761
-1,758
-9% -$73.6K
STEL
1535
DELISTED
Stellar Bancorp
STEL
$822K ﹤0.01%
26,572
-2,441
-8% -$75K
WT icon
1536
WisdomTree
WT
$3.44B
$821K ﹤0.01%
67,382
-3,192
-5% -$38.6K
PAR icon
1537
PAR Technology
PAR
$770M
$819K ﹤0.01%
22,575
-1,352
-6% -$48.8K
ANIP icon
1538
ANI Pharmaceuticals
ANIP
$1.72B
$818K ﹤0.01%
10,365
FERG icon
1539
Ferguson
FERG
$47.4B
$817K ﹤0.01%
3,669
-100
-3% -$23.9K
PPC icon
1540
Pilgrim's Pride
PPC
$6.57B
$814K ﹤0.01%
20,869
-1,083
-5% -$41.6K
CALY
1541
Callaway Golf Company
CALY
$2.95B
$810K ﹤0.01%
69,448
-6,071
-8% -$64K
SHLS icon
1542
Shoals Technologies Group
SHLS
$1.37B
$808K ﹤0.01%
95,029
NSSC icon
1543
Napco Security Technologies
NSSC
$1.39B
$807K ﹤0.01%
19,361
-1,117
-5% -$47K
HOUS
1544
DELISTED
Anywhere Real Estate
HOUS
$806K ﹤0.01%
56,951
+6,428
+13% +$78.8K
FUTU icon
1545
Futu Holdings
FUTU
$14.7B
$805K ﹤0.01%
4,900
-1,100
-18% -$189K
WLDN icon
1546
Willdan Group
WLDN
$1.29B
$804K ﹤0.01%
7,758
-466
-6% -$45.9K
VIK icon
1547
Viking Holdings
VIK
$47.3B
$804K ﹤0.01%
11,257
+98
+0.9% +$6.25K
STOK icon
1548
Stoke Therapeutics
STOK
$2.02B
$804K ﹤0.01%
25,320
GABC icon
1549
German American Bancorp
GABC
$1.91B
$803K ﹤0.01%
20,489
-1,212
-6% -$47.8K
GBX icon
1550
The Greenbrier Companies
GBX
$1.42B
$802K ﹤0.01%
17,157
-1,056
-6% -$47.4K

Similar funds

MetLife Investment Management's Q4 2025 Portfolio in Review

As of Q4 2025, MetLife Investment Management held 2,896 positions worth $20.7B, down 0.8% from $20.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2025: portfolio turnover was 4.9%. MetLife Investment Management opened 52 new positions and exited 89, leaving the 2,896-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • MetLife Investment Management's largest Q4 2025 buy was RTX Corp: 321,368 shares worth $58.9M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $54.6M increase.
  • MetLife Investment Management's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $65.1M.
  • MetLife Investment Management fully exited Kellanova in Q4 2025, selling an estimated $5.48M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $20.7B portfolio in Q4 2025.
  • MetLife Investment Management opened 52 new positions and closed 89 in Q4 2025.
  • MetLife Investment Management's portfolio value fell 0.8% quarter-over-quarter to $20.7B.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.